Introduction: Early recognition of atypical dementia remains challenging partly because of
lack of cognitive screening instruments precisely tailored for this purpose. Methods: We …

Objective To estimate the prevalence of amyloid positivity, defined by positron emission
tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, …

Background Accumulating evidence points to the superiority of the Mo CA over the MMSE as
a cognitive screening tool. To facilitate the transition from the MMSE to the Mo CA in clinical …

Structures of the medial temporal lobes are recognized to play a central role in memory
processing and to be the primary sites of deterioration in Alzheimer disease (AD). Mild cognitive …

Context The staging of Alzheimer disease (AD) dementia could be improved by a
neurometabolic analysis using magnetic resonance spectroscopy. Objective To examine the …

Recent studies have supported a role for amyloid positron emission tomography (PET)
imaging in distinguishing Alzheimer’s disease (AD) pathology from other pathological protein …

Semantic deficits have been documented in the prodromal phase of Alzheimer's disease,
but it is unclear whether these deficits are associated with non-cognitive manifestations. For …

Introduction: It is well known that some patients with Alz-heimer’s disease (AD) have atypical,
nonamnestic presentations. While logopenic aphasia and posterior cortical atrophy are well…

This retrospective study examined the role of [ 18 F]fluorodeoxyglucose positron emission
tomography (FDG-PET) in the diagnosis of atypical/unclear dementias in a memory clinic …

Background: People who are cognitively impaired not demented (CIND) can be at an
increased risk for developing dementia, but little is known about the natural history of CIND in …